Karo Pharma: Marketing Territory for Viruseptin® Extended to Include Denmark

Karo Pharma: Marketing Territory for Viruseptin® Extended to Include Denmark

PR Newswire

STOCKHOLM, Nov. 16, 2018

STOCKHOLM, Nov. 16, 2018 /PRNewswire/ --

fOr Further Information Please Contact:
Peter Blom, CEO, 070-655 56 98 or peter.blom@karopharma.se

About Karo Pharma
Karo Pharma is a specialty pharma company that develops and markets products to pharmacies and directly to healthcare providers. The share is listed on Nasdaq Stockholm in the Mid Cap segment. 

The information was submitted for publication on November 16, 2018 at 08.00 CET. This press release is also available on www.karopharma.se www.newsroom.cision.com.

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/karo-pharma/r/marketing-territory-for-viruseptin--extended-to-include-denmark,c2673802

The following files are available for download:

http://mb.cision.com/Main/72/2673802/945742.pdf

Press release (PDF)

Voltar noticias em Inglês